about
Recent developments in human immunodeficiency virus-1 latency researchBioinformatics and HIV latency.An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patientsDirectly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latencyControlling the HIV/AIDS epidemic: current status and global challengesImmunity to HIV in Early LifeA flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.Genome-wide analysis of histone modifications in latently HIV-1 infected T cells.Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.Reduced evolutionary rates in HIV-1 reveal extensive latency periods among replicating lineagesPersistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patientDynamics of HIV latency and reactivation in a primary CD4+ T cell model.Immuno-modulatory strategies for reduction of HIV reservoir cells.Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.Toll-Interacting Protein Suppresses HIV-1 Long-Terminal-Repeat-Driven Gene Expression and Silences the Post-Integrational Transcription of Viral Proviral DNA.Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.The Continuing Evolution of HIV-1 Therapy: Identification and Development of Novel Antiretroviral Agents Targeting Viral and Cellular Targets.Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switchCell-associated HIV RNA: a dynamic biomarker of viral persistence.HIV-1 transcription and latency: an update.Altering cell death pathways as an approach to cure HIV infection.Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.HDAC inhibitors in HIV.Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections.Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Feline immunodeficiency virus latency.Targeting HIV latency: resting memory T cells, hematopoietic progenitor cells and future directions.Genetic diversity and proviral DNA load in different neural compartments of HIV-1 subtype C infection.Dilazep synergistically reactivates latent HIV-1 in latently infected cells.Reactivation of latent HIV-1 by a wide variety of butyric acid-producing bacteria.A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.Peripheral immunophenotype and viral promoter variants during the asymptomatic phase of feline immunodeficiency virus infection.FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infectionIn vivo functions of CPSF6 for HIV-1 as revealed by HIV-1 capsid evolution in HLA-B27-positive subjects.Entry of HIV in primary human resting CD4(+) T cells pretreated with the chemokine CCL19.Transcriptional regulation of latent feline immunodeficiency virus in peripheral CD4+ T-lymphocytes.Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation.What do we measure when we measure cell-associated HIV RNA.Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity.
P2860
Q27013114-5946CEF9-94A2-44F4-AE6A-76B3E8907EA2Q28081427-C6B6A8A3-AF48-4FCC-9648-3A2CF22996B1Q28538015-4B3AC82B-3AE2-467D-AB48-70367A8B17BFQ28728736-1EFF54B9-C2DF-4C6B-924F-124DB9F6DED7Q30420558-5750FF50-BFD6-47AE-9BE3-4C4802CF2124Q34033051-8AB17F1F-1ABA-4050-AF77-A47661B59179Q34145909-4DC28631-22D8-400F-A0EE-8F441EA6331CQ34171188-93791EBB-D0F7-454C-962F-2F20895B3B0CQ34218827-882868BD-E345-4606-9907-DD6C5F08BF7BQ34362894-DAA7D2A4-251B-4D02-A3BE-AE2EF460BF0EQ34871994-9A3C04F8-3A34-4D15-AEE1-706CC3F27B82Q35176166-655DDE91-E71D-4FEB-8BA5-E2B8E237BFC4Q35329923-09B37C8B-6FFB-4C01-8415-08659ACC2104Q35549754-D75F156D-6E77-41E6-B81D-33B456FAD245Q35615234-97FDF88E-E320-400A-B943-FDFB471FD2EFQ35973601-519E29AE-6AB8-4CC5-B87E-D3852AAE01C8Q36104509-A4C28A8C-38F6-456E-9C72-881B10C1FD78Q36125264-85A6AA2D-0AB4-451B-A916-F1C8AAA96B90Q36798408-A654104C-9867-4B08-89A4-530A7E03A661Q36976156-581C4F22-4793-47D1-A482-976822CD74EFQ37062057-01FC9163-F028-4FC2-BE80-EB358A12F5B0Q37406571-0DC53AFE-F378-477B-B0F0-730986A80E8CQ37956178-D8D7D4A4-A246-4058-972D-874544F58DA7Q37972644-FDEE1353-C4A6-43A5-9C2D-414C6CEB9909Q38011249-DD710433-742D-4546-AD7D-CB9863014841Q38078562-04F7A29F-A0CC-4A00-A8B1-EC17B633F6FCQ38119498-55FEF31E-C578-46ED-8492-0FBAF81AED3DQ38246141-19A14DAB-6014-4D98-ACEE-FD1E29DA0024Q39031641-FF61D18D-6E24-4F36-85D1-CE6C733EB99DQ39148809-428F2CA5-7B42-48AC-B406-35E1F1D3E9F3Q39398757-C35F55AC-DBBA-42DE-9DD6-55C760B22EEFQ39794074-BD9CB1CC-C89A-4A0E-BFB0-3DD385991D3DQ40070123-AB9941D2-EFB2-4C49-BF39-71EF6C871936Q41853004-E3F91C28-2950-45CA-8EA8-00638B24B978Q41863178-E3EC448C-A164-49E1-ACFA-EA81A4028B17Q41987516-02148CDD-849B-4E98-B112-5A4340E0353BQ42220269-EECA1CD6-9818-4AD2-BB66-4D3151356022Q47201695-A95CF2D3-59E7-4C06-895F-397DB4D23285Q47548192-A771C52C-5C72-4211-A486-F8FD605619A2Q47604007-47C271A0-E693-4F09-9079-8C22EA951B3B
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
HIV reservoirs and latency models.
@en
type
label
HIV reservoirs and latency models.
@en
prefLabel
HIV reservoirs and latency models.
@en
P2093
P2860
P1433
P1476
HIV reservoirs and latency models
@en
P2093
Erin H Graf
Luis Agosto
Una O'Doherty
P2860
P304
P356
10.1016/J.VIROL.2010.12.041
P407
P577
2011-02-01T00:00:00Z